Nurix Therapeutics Inc (NRIX)

01:00 AM

Non-Hodgkin’s Lymphoma Market Forecast to Surge with Growing Adoption of Targeted and Cell-Based Therapies | DelveInsight - GlobeNewswire Inc.

01:00 AM

Jul 23, 2025

What drives Nurix Therapeutics Inc. stock pricePowerful market insights - jammulinksnews.com

Jul 23, 2025

Jul 23, 2025

Is Nurix Therapeutics Inc. a good long term investmentExceptional trading results - Autocar Professional

Jul 23, 2025

Jul 23, 2025

Nurix Therapeutics Inc. Stock Analysis and ForecastMarket-beating returns - jammulinksnews.com

Jul 23, 2025

Jul 23, 2025

Hussman Strategic Advisors Inc. Takes Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

Jul 23, 2025

Jul 22, 2025

Nurix Therapeutics (NASDAQ:NRIX) Stock Price Down 5.4%What's Next? - MarketBeat

Jul 22, 2025

Jul 22, 2025

Janux Therapeutics Receives Buy Rating from Leerink Partners Amid Strategic Initiatives and Long-Term Growth Potential - AInvest

Jul 22, 2025

Jul 22, 2025

Massachusetts Financial Services Co. MA Has $511,000 Stock Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

Jul 22, 2025

Jul 22, 2025

What analysts say about Nurix Therapeutics Inc. stockUnmatched profit potential - jammulinksnews.com

Jul 22, 2025

Jul 19, 2025

Q3 EPS Forecast for Nurix Therapeutics Raised by Analyst - MarketBeat

Jul 19, 2025

Jul 18, 2025

Janux Therapeutics (JANX) Soars 2.31% on R&D Day Announcement - AInvest

Jul 18, 2025

Jul 17, 2025

Nurix Therapeutics’ SWOT analysis: biotech stock’s pivotal trials and pipeline progress By Investing.com - Investing.com South Africa

Jul 17, 2025

Jul 17, 2025

Nurix Therapeutics’ SWOT analysis: biotech stock’s pivotal trials and pipeline progress - Investing.com Australia

Jul 17, 2025

Jul 17, 2025

When (NRIX) Moves Investors should Listen - news.stocktradersdaily.com

Jul 17, 2025

Jul 15, 2025

Nurix Therapeutics price target lowered to $34 from $36 at H.C. Wainwright - Yahoo Finance

Jul 15, 2025

Jul 15, 2025

NRIX: Morgan Stanley Lowers Price Target for Nurix Therapeutics - GuruFocus

Jul 15, 2025

Jul 14, 2025

A Glimpse Into The Expert Outlook On Nurix Therapeutics Through 5 Analysts - Benzinga

Jul 14, 2025

Jul 14, 2025

Nurix Therapeutics (NASDAQ:NRIX) Price Target Lowered to $34.00 at HC Wainwright - MarketBeat

Jul 14, 2025

Jul 14, 2025

H.C. Wainwright Adjusts Price Target for Nurix Therapeutics (NRI - GuruFocus

Jul 14, 2025

Jul 14, 2025

Navigating Nurix Therapeutics' Early-Stage Biotech Landscape: A Strategic SWOT Analysis - AInvest

Jul 14, 2025

Jul 14, 2025

Broker Revenue Forecasts For Nurix Therapeutics, Inc. (NASDAQ:NRIX) Are Surging Higher - simplywall.st

Jul 14, 2025

Jul 13, 2025

Nurix Therapeutics (NASDAQ:NRIX) Shares Gap Up on Better-Than-Expected Earnings - MarketBeat

Jul 13, 2025

Jul 13, 2025

Nurix Therapeutics (NASDAQ:NRIX) Price Target Cut to $30.00 by Analysts at Oppenheimer - MarketBeat

Jul 13, 2025

Jul 13, 2025

Nurix Therapeutics (NASDAQ:NRIX) Issues Earnings Results - MarketBeat

Jul 13, 2025

Jul 13, 2025

Nurix Therapeutics: The BTK Disruptor With Undervalued Upside Potential - AInvest

Jul 13, 2025

Jul 13, 2025

Nurix Therapeutics Could Disrupt BTK Therapy And Reward Investors (NASDAQ:NRIX) - Seeking Alpha

Jul 13, 2025

Jul 13, 2025

Nurix Therapeutics' (NRIX) "Overweight" Rating Reaffirmed at Stephens - MarketBeat

Jul 13, 2025

Jul 12, 2025

Nurix Therapeutics (NASDAQ:NRIX) Shares Up 7.8% After Earnings Beat - MarketBeat

Jul 12, 2025

Jul 11, 2025

Top 3 Trending Stocks: Ultragenyx Pharmaceutical, Rhythm Pharmaceuticals, and Nurix Therapeutics - AInvest

Jul 11, 2025

Jul 11, 2025

Stifel Nicolaus Keeps Their Buy Rating on Nurix Therapeutics (NRIX) - The Globe and Mail

Jul 11, 2025

Jul 11, 2025

Piper Sandler Keeps Their Buy Rating on Nurix Therapeutics (NRIX) - The Globe and Mail

Jul 11, 2025

Jul 10, 2025

Nurix Therapeutics (NRIX) Stock Target Price Lowered by UBS Anal - GuruFocus

Jul 10, 2025

Jul 10, 2025

UBS Group Cuts Nurix Therapeutics (NASDAQ:NRIX) Price Target to $26.00 - MarketBeat

Jul 10, 2025

Jul 10, 2025

Mixed Moves In Health And Biotech Funds - Finimize

Jul 10, 2025

Jul 10, 2025

Oppenheimer Adjusts Price Target on Nurix Therapeutics to $30 From $32, Maintains Outperform Rating - MarketScreener

Jul 10, 2025